Two new reports from iData Research cover the US market for vascular access devices and the European markets for cardiac surgery and heart valve devices. The European interventional cardiology report covers markets for tissue heart ...
Tags: Medtech Markets, US market
Vancouver-based Neovasc has announced that its Tiara mitral valve has been successfully implanted in a human patient on January, 30, 2014. Following the announcement on February 3, the company's stock jumped up 35.17%. The device, which ...
Tags: Mitral Valve, health
Duke University’s Duke Clinical Research Institute (DCRI) has been selected by Oxygen Biotherapeutics, a pharmaceutical company, to conduct the Phase III clinical trial of the company’s newly acquired compound, levosimendan. ...
Neovasc, a medical device company, has obtained the first patent from the US Patent and Trademark Office (USPTO) for its Tiara transcatheter mitral valve replacement technology. The new patent, entitled 'Transcatheter Mitral Valve ...
US-based Abbott Laboratories has obtained an approval from the US Food and Drug Administration (FDA) for its MitraClip device, designed to treat patients with significant symptomatic degenerative mitral regurgitation (MR) who are at ...
Tags: FDA Approval, Abbott
Royal Philips Electronics has launched new Epiq premium ultrasound system designed to visualize deeper levels of anatomical detail and contrast resolution on patients of all types. Epiq, the new ultrasound system which features nSIGHT ...
Abbott has presented clinical study data from a Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II ) High Surgical Risk cohort of its MitraClip System for the treatment of mitral regurgitation (MR). The CE-marked catheter-based ...
Tags: clinical study, MitraClip System, medical
The European Union has granted CE mark to NeoChord's minimally invasive device, DS1000, that allows implantation of artificial chordae tendinae for the repair of mitral valve prolapse, via a transapical, off-pump procedure. In addition, ...
Tags: European Union, CE mark, NeoChord's minimally invasive device, Medicine
The US Food and Drug Administration (FDA) has granted 510(k) approval to Cardiosolutions' Dexterity Steerable Introducer. The Dexterity Steerable Introducer is designed to simplify the cardiac trans-septal procedure and facilitates ...
MitrAssist Medical has obtained ISO 13485:2003 certification for the design of implantable mitral valve prostheses. By using a minimally invasive procedure, the mitral valve prosthesis is delivered via a small-diameter catheter, thus ...
Tags: MitrAssist, ISO certification, mitral valve prostheses